(9) discovered EGFR to be a critical driver mutation in PEAC, but its incidence was lower than that of classic lung adenocarcinoma, in contrast to ERBB2 and KRAS, which were more common in PEAC. This evidence concerns the gene ERBB2 and lung adenocarcinoma.